Home › Novartis sees Q4 profit rise 72 per cent to $2.1B without charges
 

Keywords :   


Novartis sees Q4 profit rise 72 per cent to $2.1B without charges

2013-01-23 10:10:28| Biotech - Topix.net

The result is 72 per cent higher than the $1.21 billion net profit reported for the last quarter of 2011 when the Basel-based company took a $900-million charge after ending its clinical study into wider uses of the hypertension drug Tekturna.

Tags: without rise charges profit

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Public Advisory Number 27A
05.07Atlantic Tropical Weather Outlook
05.07Eastern North Pacific Tropical Weather Outlook
05.07Summary for Hurricane Beryl (AT2/AL022024)
05.07Are manure pumping practices impacting PRRSV, PEDV spread?
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Forecast Discussion Number 27
More »